Skip to main content
Erschienen in: Clinical and Experimental Nephrology 5/2009

01.10.2009 | Original Article

Utility and feasibility of a new programmable home blood pressure monitoring device for the assessment of nighttime blood pressure

verfasst von: Hisako Ushio, Tomoaki Ishigami, Naomi Araki, Shintaro Minegishi, Koichi Tamura, Yasuko Okano, Kazuaki Uchino, Osamu Tochikubo, Satoshi Umemura

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Recent evidence indicates that both ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM) are more useful than the measurement of office blood pressure for evaluating cardiovascular risks in subjects with hypertension. The major advantage of ABPM over HBPM is the ability to measure nighttime blood pressure and ambulatory blood pressure during the day. A newly developed, programmable HBPM device (HEM-5041, OMRON, Kyoto, Japan) can record blood pressure up to 350 times and measure nighttime blood pressure automatically.

Methods

To validate the utility, feasibility, and safety of this device, we measured blood pressure by HBPM using HEM-5041 and by ABPM and compared the values in healthy volunteers.

Results

As compared with ABPM, daytime blood pressures, coefficients of variation for systolic blood pressure, diastolic blood pressure, and pulse rate, and the percentage nighttime fall in these variables were significantly lower with HBPM. However, nighttime blood pressures did not significantly differ between HBPM and ABPM. The results of a questionnaire survey indicated that the subjects were more comfortable when blood pressure was measured by HBPM than by ABPM, whereas the quality of sleep was similar.

Conclusions

Our results suggest that HEM-5041 is useful for evaluating nighttime blood pressures as well as nighttime blood pressure falls, without causing clinically significant discomfort.
Literatur
1.
Zurück zum Zitat Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202:1028–34.CrossRef Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202:1028–34.CrossRef
2.
Zurück zum Zitat Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA. 1970;213:1143–52.CrossRef Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA. 1970;213:1143–52.CrossRef
3.
Zurück zum Zitat Anan F, Masaki T, Fukunaga N, Teshima Y, Iwao T, Kaneda K, et al. Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus. Eur J Clin Invest. 2007;37:709–14.CrossRefPubMed Anan F, Masaki T, Fukunaga N, Teshima Y, Iwao T, Kaneda K, et al. Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus. Eur J Clin Invest. 2007;37:709–14.CrossRefPubMed
4.
Zurück zum Zitat Ohkubo T, Metoki H, Imai Y. Prognostic significance of morning surge in blood pressure: which definition, which outcome? Blood Press Monit. 2008;13:161–2.CrossRefPubMed Ohkubo T, Metoki H, Imai Y. Prognostic significance of morning surge in blood pressure: which definition, which outcome? Blood Press Monit. 2008;13:161–2.CrossRefPubMed
5.
Zurück zum Zitat Fukunaga H, Ohkubo T, Kobayashi M, Tamaki Y, Kikuya M, Obara T, et al. Cost-effectiveness of the introduction of home blood pressure measurement in patients with office hypertension. J Hypertens. 2008;26:685–90.CrossRefPubMed Fukunaga H, Ohkubo T, Kobayashi M, Tamaki Y, Kikuya M, Obara T, et al. Cost-effectiveness of the introduction of home blood pressure measurement in patients with office hypertension. J Hypertens. 2008;26:685–90.CrossRefPubMed
6.
Zurück zum Zitat Shintani Y, Kikuya M, Hara A, Ohkubo T, Metoki H, Asayama K, et al. Ambulatory blood pressure, blood pressure variability and the prevalence of carotid artery alteration: the Ohasama study. J Hypertens. 2007;25:1704–10.CrossRefPubMed Shintani Y, Kikuya M, Hara A, Ohkubo T, Metoki H, Asayama K, et al. Ambulatory blood pressure, blood pressure variability and the prevalence of carotid artery alteration: the Ohasama study. J Hypertens. 2007;25:1704–10.CrossRefPubMed
7.
Zurück zum Zitat Ohkubo T. Prognostic significance of variability in ambulatory and home blood pressure from the Ohasama study. J Epidemiol. 2007;17:109–13.CrossRefPubMed Ohkubo T. Prognostic significance of variability in ambulatory and home blood pressure from the Ohasama study. J Epidemiol. 2007;17:109–13.CrossRefPubMed
8.
Zurück zum Zitat Kikuya M, Hansen TW, Thijs L, Bjorklund-Bodegard K, Kuznetsova T, Ohkubo T, et al. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007;115:2145–52.CrossRefPubMed Kikuya M, Hansen TW, Thijs L, Bjorklund-Bodegard K, Kuznetsova T, Ohkubo T, et al. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007;115:2145–52.CrossRefPubMed
9.
Zurück zum Zitat Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219–29.CrossRefPubMed Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219–29.CrossRefPubMed
10.
Zurück zum Zitat Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998;16:971–5.CrossRefPubMed Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998;16:971–5.CrossRefPubMed
11.
Zurück zum Zitat Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, et al. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens. 2004;22:1099–104.CrossRefPubMed Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, et al. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens. 2004;22:1099–104.CrossRefPubMed
12.
Zurück zum Zitat Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291:1342–9.CrossRefPubMed Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291:1342–9.CrossRefPubMed
13.
Zurück zum Zitat Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777–83.CrossRefPubMed Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777–83.CrossRefPubMed
14.
Zurück zum Zitat Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators. JAMA. 1999;282:539–46.CrossRefPubMed Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators. JAMA. 1999;282:539–46.CrossRefPubMed
15.
Zurück zum Zitat El Assaad MA, Topouchian JA, Asmar RG. Evaluation of two devices for self-measurement of blood pressure according to the international protocol: the Omron M5-I and the Omron 705IT. Blood Press Monit. 2003;8:127–33.CrossRefPubMed El Assaad MA, Topouchian JA, Asmar RG. Evaluation of two devices for self-measurement of blood pressure according to the international protocol: the Omron M5-I and the Omron 705IT. Blood Press Monit. 2003;8:127–33.CrossRefPubMed
16.
Zurück zum Zitat Coleman A, Freeman P, Steel S, Shennan A. Validation of the Omron 705IT (HEM-759-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol. Blood Press Monit. 2006;11:27–32.CrossRefPubMed Coleman A, Freeman P, Steel S, Shennan A. Validation of the Omron 705IT (HEM-759-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol. Blood Press Monit. 2006;11:27–32.CrossRefPubMed
17.
Zurück zum Zitat Stergiou GS, Yiannes NG, Rarra VC. Validation of the Omron 705 IT oscillometric device for home blood pressure measurement in children and adolescents: the Arsakion School Study. Blood Press Monit. 2006;11:229–34.CrossRefPubMed Stergiou GS, Yiannes NG, Rarra VC. Validation of the Omron 705 IT oscillometric device for home blood pressure measurement in children and adolescents: the Arsakion School Study. Blood Press Monit. 2006;11:229–34.CrossRefPubMed
18.
Zurück zum Zitat Topouchian JA, El Assaad MA, Orobinskaia LV, El Feghali RN, Asmar RG. Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT). Blood Press Monit. 2006;11:165–71.CrossRefPubMed Topouchian JA, El Assaad MA, Orobinskaia LV, El Feghali RN, Asmar RG. Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT). Blood Press Monit. 2006;11:165–71.CrossRefPubMed
19.
Zurück zum Zitat Altunkan S, Iliman N, Altunkan E. Validation of the Omron M6 (HEM-7001-E) upper arm blood pressure measuring device according to the International Protocol in elderly patients. Blood Press Monit. 2008;13:117–22.CrossRefPubMed Altunkan S, Iliman N, Altunkan E. Validation of the Omron M6 (HEM-7001-E) upper arm blood pressure measuring device according to the International Protocol in elderly patients. Blood Press Monit. 2008;13:117–22.CrossRefPubMed
20.
Zurück zum Zitat Palatini P, Frigo G, Bertolo O, Roman E, Da Corta R, Winnicki M. Validation of the A&D TM-2430 device for ambulatory blood pressure monitoring and evaluation of performance according to subjects’ characteristics. Blood Press Monit. 1998;3:255–60.PubMed Palatini P, Frigo G, Bertolo O, Roman E, Da Corta R, Winnicki M. Validation of the A&D TM-2430 device for ambulatory blood pressure monitoring and evaluation of performance according to subjects’ characteristics. Blood Press Monit. 1998;3:255–60.PubMed
21.
Zurück zum Zitat Cuspidi C, Meani S, Salerno M, Valerio C, Fusi V, Severgnini B, et al. Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure. J Hypertens. 2004;22:273–80.CrossRefPubMed Cuspidi C, Meani S, Salerno M, Valerio C, Fusi V, Severgnini B, et al. Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure. J Hypertens. 2004;22:273–80.CrossRefPubMed
22.
Zurück zum Zitat Imai Y. Clinical significance and cost-effectiveness of 24-hour ambulatory blood pressure monitoring. Tohoku J Exp Med. 1995;176:1–15.CrossRefPubMed Imai Y. Clinical significance and cost-effectiveness of 24-hour ambulatory blood pressure monitoring. Tohoku J Exp Med. 1995;176:1–15.CrossRefPubMed
23.
Zurück zum Zitat Sakuma M, Imai Y, Nagai K, Watanabe N, Sakuma H, Minami N, et al. Reproducibility of home blood pressure measurements over a 1-year period. Am J Hypertens. 1997;10:798–803.CrossRefPubMed Sakuma M, Imai Y, Nagai K, Watanabe N, Sakuma H, Minami N, et al. Reproducibility of home blood pressure measurements over a 1-year period. Am J Hypertens. 1997;10:798–803.CrossRefPubMed
24.
Zurück zum Zitat Ozawa M, Tamura K, Iwatsubo K, Matsushita K, Sakai M, Tsurumi-Ikeya Y, et al. Ambulatory blood pressure variability is increased in diabetic hypertensives. Clin Exp Hypertens. 2008;30:213–24.CrossRefPubMed Ozawa M, Tamura K, Iwatsubo K, Matsushita K, Sakai M, Tsurumi-Ikeya Y, et al. Ambulatory blood pressure variability is increased in diabetic hypertensives. Clin Exp Hypertens. 2008;30:213–24.CrossRefPubMed
25.
Zurück zum Zitat Tamura K, Tsurumi Y, Sakai M, Tanaka Y, Okano Y, Yamauchi J, et al. A possible relationship of nocturnal blood pressure variability with coronary artery disease in diabetic nephropathy. Clin Exp Hypertens. 2007;29:31–42.CrossRefPubMed Tamura K, Tsurumi Y, Sakai M, Tanaka Y, Okano Y, Yamauchi J, et al. A possible relationship of nocturnal blood pressure variability with coronary artery disease in diabetic nephropathy. Clin Exp Hypertens. 2007;29:31–42.CrossRefPubMed
26.
Zurück zum Zitat Chamontin B, Amar J, Garelli-Flores II, Salvador M. Dippers and non-dippers among overweight hypertensive men. Blood Press Monit. 1996;1:329–32.PubMed Chamontin B, Amar J, Garelli-Flores II, Salvador M. Dippers and non-dippers among overweight hypertensive men. Blood Press Monit. 1996;1:329–32.PubMed
27.
Zurück zum Zitat Butkevich A, Phillips RA, Sheinart KF, Tuhrim S. The effects of various definitions of dipping and daytime and night-time on the characterization of 24 h profiles of blood pressure. Blood Press Monit. 2000;5:19–22.CrossRefPubMed Butkevich A, Phillips RA, Sheinart KF, Tuhrim S. The effects of various definitions of dipping and daytime and night-time on the characterization of 24 h profiles of blood pressure. Blood Press Monit. 2000;5:19–22.CrossRefPubMed
28.
Zurück zum Zitat Manning G, Rushton L, Donnelly R, Millar-Craig MW. Variability of diurnal changes in ambulatory blood pressure and nocturnal dipping status in untreated hypertensive and normotensive subjects. Am J Hypertens. 2000;13:1035–8.CrossRefPubMed Manning G, Rushton L, Donnelly R, Millar-Craig MW. Variability of diurnal changes in ambulatory blood pressure and nocturnal dipping status in untreated hypertensive and normotensive subjects. Am J Hypertens. 2000;13:1035–8.CrossRefPubMed
29.
Zurück zum Zitat Sturrock ND, George E, Pound N, Stevenson J, Peck GM, Sowter H. Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet Med. 2000;17:360–4.CrossRefPubMed Sturrock ND, George E, Pound N, Stevenson J, Peck GM, Sowter H. Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet Med. 2000;17:360–4.CrossRefPubMed
30.
Zurück zum Zitat Hermida RC, Ayala DE, Portaluppi F. Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv Drug Deliv Rev. 2007;59:904–22.CrossRefPubMed Hermida RC, Ayala DE, Portaluppi F. Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv Drug Deliv Rev. 2007;59:904–22.CrossRefPubMed
31.
Zurück zum Zitat Mansoor GA. Sleep actigraphy in hypertensive patients with the ‘non-dipper’ blood pressure profile. J Hum Hypertens. 2002;16:237–42.CrossRefPubMed Mansoor GA. Sleep actigraphy in hypertensive patients with the ‘non-dipper’ blood pressure profile. J Hum Hypertens. 2002;16:237–42.CrossRefPubMed
32.
Zurück zum Zitat Coca A. Circadian rhythm and blood pressure control: physiological and pathophysiological factors. J Hypertens Suppl. 1994;12:S13–21.CrossRefPubMed Coca A. Circadian rhythm and blood pressure control: physiological and pathophysiological factors. J Hypertens Suppl. 1994;12:S13–21.CrossRefPubMed
33.
Zurück zum Zitat Uzu T, Nishimura M, Fujii T, Takeji M, Kuroda S, Nakamura S, et al. Changes in the circadian rhythm of blood pressure in primary aldosteronism in response to dietary sodium restriction and adrenalectomy. J Hypertens. 1998;16:1745–8.CrossRefPubMed Uzu T, Nishimura M, Fujii T, Takeji M, Kuroda S, Nakamura S, et al. Changes in the circadian rhythm of blood pressure in primary aldosteronism in response to dietary sodium restriction and adrenalectomy. J Hypertens. 1998;16:1745–8.CrossRefPubMed
34.
Zurück zum Zitat Okuguchi T, Osanai T, Kamada T, Kimura M, Takahashi K, Okumura K. Significance of sympathetic nervous system in sodium-induced nocturnal hypertension. J Hypertens. 1999;17:947–57.CrossRefPubMed Okuguchi T, Osanai T, Kamada T, Kimura M, Takahashi K, Okumura K. Significance of sympathetic nervous system in sodium-induced nocturnal hypertension. J Hypertens. 1999;17:947–57.CrossRefPubMed
35.
Zurück zum Zitat Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:1–9.CrossRefPubMed Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:1–9.CrossRefPubMed
36.
Zurück zum Zitat Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:10–29.CrossRefPubMedPubMedCentral Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:10–29.CrossRefPubMedPubMedCentral
Metadaten
Titel
Utility and feasibility of a new programmable home blood pressure monitoring device for the assessment of nighttime blood pressure
verfasst von
Hisako Ushio
Tomoaki Ishigami
Naomi Araki
Shintaro Minegishi
Koichi Tamura
Yasuko Okano
Kazuaki Uchino
Osamu Tochikubo
Satoshi Umemura
Publikationsdatum
01.10.2009
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 5/2009
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-009-0192-4

Weitere Artikel der Ausgabe 5/2009

Clinical and Experimental Nephrology 5/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.